Mansalinog, Emilyn B.

HRN: 22-26-8401  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/30/2022
CEFUROXIME 1.5GM (VIAL)
12/30/2022
12/30/2022
IV
1.5 Grams
On Call To OR
For Repeat CS
Waiting Final Action 
12/30/2022
CEFUROXIME 1.5GM (VIAL)
12/30/2022
01/05/2023
IV
1.5
Q8H
S/p CS
Waiting Final Action 
12/30/2022
CEFUROXIME 1.5GM (VIAL)
12/30/2022
01/05/2023
IV
1.5
Q8H
S/p CS
Waiting Final Action 
01/02/2023
METRONIDAZOLE 500MG (TAB)
01/02/2023
01/08/2023
ORAL
500 Mg
TID
AMOEBIASIS
Waiting Final Action 
01/05/2023
CEFUROXIME 1.5GM (VIAL)
01/05/2023
01/11/2023
IV
1.5
Q8H
AGE W/ Mild DHN
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: